Here’s whether Sabra Healthcare REIT, Inc. (SBRA) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.14% over 10 days); 3-month momentum negative (-10.4%); rising volume on a downtrend (distribution, 1.37x avg). Currently 12.0% off its 52-week high. Score: -5/7.
SBRA is trading below its 200-day MA ($19.33) — a key warning sign the longer-term trend is under pressure. An RSI of 32.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +2.1% compares to +22.9% for SPY (trailed the market by 20.7%).
$10,000 invested 1 year ago→ $10,213 today
vs. S&P 500 (SPY) — same period trailed market by 20.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($19.33)
✗Above 50-day MA ($20.07)
✓RSI(14) neutral zone (30–70) — currently 32.5
✓Positive return (+2.1%)
!Within 10% of period high (−12.0%)
Period Range $18.73
$17.17$21.28
RSI (14) 32.5
0 · OversoldOverbought · 100
Key Metrics
Price$18.73
Period Return+2.1%
Period High$21.28
Period Low$17.17
Drawdown−12.0%
MA-50$20.07
MA-200$19.33
RSI (14)32.5
Avg Volume (30d)2.5M
vs. SPYtrailed by 20.7%
Return Rank#686 of 1246
Trend Signals
Price is below the 200-day moving average ($19.33)